@article{article, title = {{Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.}}, url = {{}}, year = {{2003}}, month = {{3}}, author = {{Chilcott J and McCabe C and Tappenden P and O'Hagan A and Cooper NJ and Abrams K and Claxton K and Miller DH and Cost Effectiveness of Multiple Sclerosis Therapies Study Group}}, doi = {{10.1136/bmj.326.7388.522}}, volume = {{326}}, journal = {{BMJ}}, issue = {{7388}}, pages = {{522}}, note = {{Accessed on 2025/04/12}}}